Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/med.21783 http://scihub22266oqcxt.onion/10.1002/med.21783 33460213!8014231!33460213     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Res+Rev 2021 ; 41 (4): 1965-1998 Nephropedia Template TP {{tp|p=33460213|t=2021. What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design |pdf=|usr=}}{{33460213}} gab.com Text What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design JO: Med Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=33460213 #FOAvip The emergence of a variety of coronaviruses (CoVs) in the last decades has posed huge threats to human health. Especially, the ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to more than 70 million infections and over 1.6 million of deaths worldwide in the past few months. None of the efficacious antiviral agents against human CoVs have been approved yet. 3C-like protease (3CL(pro) ) is an attractive target for antiviral intervention due to its essential role in processing polyproteins translated from viral RNA, and its conserved structural feature and substrate specificity among CoVs in spite of the sequence variation. This review focuses on all available crystal structures of 12 CoV 3CL(pro) s and their inhibitors, and intends to provide a comprehensive understanding of this protease from multiple aspects including its structural features, substrate specificity, inhibitor binding modes, and more importantly, to recapitulate the similarity and diversity among different CoV 3CL(pro) s and the structure-activity relationship of various types of inhibitors. Such an attempt could gain a deep insight into the inhibition mechanisms and drive future structure-based drug discovery targeting 3CL(pro) s. Twit Text FOAVip What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design ????Med Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=33460213 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33460213 #FOAvip English Wikipedia <ref>{{Cite pmid|33460213}}</ref> What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design #MMPMID33460213 Xiong M; Su H; Zhao W; Xie H; Shao Q; Xu Y Med Res Rev 2021[Jul]; 41 (4): 1965-1998 PMID33460213show ga The emergence of a variety of coronaviruses (CoVs) in the last decades has posed huge threats to human health. Especially, the ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to more than 70 million infections and over 1.6 million of deaths worldwide in the past few months. None of the efficacious antiviral agents against human CoVs have been approved yet. 3C-like protease (3CL(pro) ) is an attractive target for antiviral intervention due to its essential role in processing polyproteins translated from viral RNA, and its conserved structural feature and substrate specificity among CoVs in spite of the sequence variation. This review focuses on all available crystal structures of 12 CoV 3CL(pro) s and their inhibitors, and intends to provide a comprehensive understanding of this protease from multiple aspects including its structural features, substrate specificity, inhibitor binding modes, and more importantly, to recapitulate the similarity and diversity among different CoV 3CL(pro) s and the structure-activity relationship of various types of inhibitors. Such an attempt could gain a deep insight into the inhibition mechanisms and drive future structure-based drug discovery targeting 3CL(pro) s. |*Drug Discovery[MESH] |Antiviral Agents/*pharmacology[MESH] |Binding Sites[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus 3C Proteases/*antagonists & inhibitors/*chemistry[MESH] |Drug Design[MESH] |Humans[MESH] |Protein Conformation[MESH] |Protein Structure, Quaternary[MESH] |SARS-CoV-2/drug effects[MESH] |Structure-Activity Relationship[MESH]What coronavirus 3C-like protease tells us: From structure, substrate (epmc).pdf DeepDyve Pubget Overpricing